Revolution Medicines Inc (RVMD)
38.97
-1.23
(-3.06%)
USD |
NASDAQ |
May 06, 13:33
Revolution Medicines Accounts Payable (Quarterly): 61.79M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 61.79M |
September 30, 2023 | 29.63M |
June 30, 2023 | 29.78M |
March 31, 2023 | 19.91M |
December 31, 2022 | 21.31M |
September 30, 2022 | 24.38M |
June 30, 2022 | 14.07M |
March 31, 2022 | 14.17M |
December 31, 2021 | 14.06M |
September 30, 2021 | 10.49M |
Date | Value |
---|---|
June 30, 2021 | 10.44M |
March 31, 2021 | 9.65M |
December 31, 2020 | 12.61M |
September 30, 2020 | 6.656M |
June 30, 2020 | 10.17M |
March 31, 2020 | 7.877M |
December 31, 2019 | 11.40M |
September 30, 2019 | 6.013M |
December 31, 2018 | 5.236M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
6.013M
Minimum
Sep 2019
61.79M
Maximum
Dec 2023
17.47M
Average
13.33M
Median
Accounts Payable (Quarterly) Benchmarks
Cutera Inc | 19.83M |
BioSig Technologies Inc | -- |
TRACON Pharmaceuticals Inc | 2.544M |
Zentalis Pharmaceuticals Inc | 14.93M |
Day One Biopharmaceuticals Inc | 2.576M |